Kura Oncology Stock Performance
Trading Session Kura Oncology (NASDAQ: KURA) closed 6.62 % higher at 05:42 AM Central Europe on Thursday, 22 October 2026. The closing price was USD 9.88 per share.
Market Data
Shares outstanding: 89 million.
Market capitalization: USD 832.7 million.
24‑hour trading volume: USD 15.4 million.
200‑day simple moving average: USD 9.78.
52‑week high: USD 13.90 (recorded 25 August 2026).
52‑week low: USD 7.36 (recorded 5 February 2026).
Recent Trend Since the end of the previous month, KURA shares have fallen 13.97 %.
Performance of Related Companies (Last 24 Hours)
| Symbol | Change | Current Price | Market Cap |
|---|---|---|---|
| HBNC (Horizon) | +2.5 % | USD 19.60 | USD 986.8 million |
| CSTL (Castle Biosciences) | +3.06 % | USD 34.37 | USD 982.6 million |
| UVV (Universal /Va) | +0.2 % | USD 38.22 | USD 985 million |
| MNKD (Mannkind) | +0.32 % | USD 3.05 | USD 993.6 million |
| CBLL (Ceribell) | +6.46 % | USD 27.14 | USD 997.8 million |
Note: UVV’s price‑to‑earnings ratio is 51.93.
Company Overview
Kura Oncology, Inc. is a clinical‑stage biopharmaceutical firm headquartered in La Jolla, California. The company focuses on the discovery and development of personalized therapies for solid and hematologic tumors, including lung, colorectal, thyroid, blood, and pancreatic cancers. Kura Oncology’s programs target cancers with high unmet medical need. The company’s website is www.kuraoncology.com and its shares trade on the Nasdaq exchange.
